After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Relay Therapeutics Inc is $376.34M. A total of 2.16 million shares were traded on the day, compared to an average of 2.59M shares.
In the most recent transaction, Bergstrom Donald A sold 986 shares of RLAY for 2.84 per share on Mar 27 ’25. After the transaction, the President, R&D now owns 615,052 company shares. In a previous transaction on Mar 27 ’25, Rahmer Peter sold 247 shares at 2.84 per share. RLAY shares that the insider owns now total 402,184.
Among the insiders who sold shares, Catinazzo Thomas disposed of 4,864 shares on Mar 27 ’25 at a per-share price of $2.84. This resulted in the Chief Financial Officer holding 374,567 shares of RLAY after the transaction. In another insider transaction, Adams Brian sold 298 shares at $2.84 per share on Mar 27 ’25. Company shares held by the Chief Legal Officer now total 405,972.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, RLAY has a high of $10.72 and a low of $1.77.
As of this writing, RLAY has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.47 per share and a lower estimate of -$0.6.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $4.64, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.85.
